FUREN Group Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 902.258 million compared to CNY 1,339.624 million a year ago. Operating loss was CNY 299.040 million compared to operating Income of CNY 95.273 million a year ago. Net loss was CNY 294.246 million compared to net income of CNY 68.116 million a year ago. Basic loss per share from continuing operations was CNY 0.47 compared to basic earnings per share from continuing operations of CNY 0.11 a year ago.